Hydrochlorothiazide for Prevention of Kidney Stones

Introduction to Hydrochlorothiazide Therapy

Hydrochlorothiazide is effective in preventing recurrent calcium kidney stones, particularly in patients with hypercalciuria, and should be offered as a pharmacological treatment option when increased fluid intake fails to prevent stone recurrence, as recommended by the American College of Physicians and the American Urological Association 1, 2

Hydrochlorothiazide reduces urinary calcium excretion, which is a key factor in calcium stone formation, with the American Urological Association specifically recommending thiazide diuretics for patients with high or relatively high urine calcium and recurrent calcium stones (Standard; Evidence Strength: Grade B) 2, 4
The American College of Physicians recommends thiazide diuretics as an effective pharmacological monotherapy for preventing recurrent nephrolithiasis when increased fluid intake alone is insufficient, with a strength of evidence supporting its use 1, 3

Thiazide dosages associated with a hypocalciuric effect include hydrochlorothiazide (25 mg orally, twice daily; 50 mg orally, once daily), with the American Urological Association recommending these dosages for patients with calcium stones 2, 4
Thiazides are most appropriate for patients with calcium stones, which are the most common type, and are particularly beneficial for patients with hypercalciuria, as stated by the American College of Physicians 1, 3

Dietary sodium restriction should be continued when thiazides are prescribed to maximize the hypocalciuric effect and limit potassium wasting, as recommended by the American Urological Association 2, 4
The first-line approach for preventing kidney stones is to increase fluid intake to achieve urine output of at least 2 liters per day, with pharmacological therapy considered if stone formation persists, according to the American College of Physicians 1, 5

Obtain a 24-hour urine specimen within six months of initiating treatment to assess response to therapy, and monitor for side effects, particularly hypokalemia, which may require potassium supplementation, as recommended by the American Urological Association 2, 4
Inadequate fluid intake remains a major risk factor for stone recurrence regardless of pharmacological intervention, highlighting the importance of continued dietary modifications alongside pharmacological therapy for optimal results, as stated by the American College of Physicians 6, 5